Assessing Immunogenicity Using Ex Vivo T cell Assays

BPI Contributor

December 5, 2014

1 Min Read
Assessing Immunogenicity Using Ex Vivo T cell Assays


This article discusses Antitope’s developed highly sensitive ex vivo T cell assay technology that can detect T cell responses against T cell epitopes in therapeutic proteins. These assays can be used to select non-immunogenic lead proteins as well as support the optimisation of leads by engineering out T cell epitopes

You May Also Like